We have performed B2 microglobulin determination in 18 non-cancer and in 38 cancer cases. We found a higher value in the control group in 11% (2 cases) and a pathologic value in 43.5% (17 cases) in the group of patients with primary bronchial cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000225287 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!